Pricing Log in Create free account

Oramed Pharmaceuticals Inc. (ORMP) vs Whitehawk Therapeutics, Inc. (WHWK)

Oramed Pharmaceuticals Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Whitehawk Therapeutics, Inc. is the larger, with a market value of $178.4M against $160.6M — 1.1× the size. Whitehawk Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 48.8% against 16.5%. Across the 14 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and Whitehawk Therapeutics, Inc. on 6.

Valuation

Metric ORMP WHWK Biotechnology median
P/E 0.91 n/m 10.60
P/S 39.40 9.34 9.40
P/B 0.50 1.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 26.81 2.54 9.02
Earnings yield 109.59% (35.78%) (32.88%)
Free cash flow yield (3.29%) (26.94%) (23.13%)

Profitability

Metric ORMP WHWK Biotechnology median
Gross margin 32.31% 88.72% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 73.90% (44.98%) (51.96%)
Return on assets 65.52% (42.60%) (46.06%)
Return on invested capital (3.40%) 0.00% 0.00%

Growth

Metric ORMP WHWK Biotechnology median
Revenue growth (TTM) 48.76% 16.51% 6.76%
EPS growth (last fiscal year) 412.50% 86.02% 29.88%
Revenue growth, 5-year CAGR (5.85%) (13.29%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP WHWK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 17.38 4.97
Net debt to EBITDA 8.41 1.26 1.01

Dividend

Metric ORMP WHWK Biotechnology median
Dividend yield 6.48% — 0.41%
Payout ratio 0.06 — —

Size

Metric ORMP WHWK Biotechnology median
Market cap 160.57m 178.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack